Pharma ingredients insured structure
Marketplace opportunity memo with economics, protections, and due diligence perimeter.
Insured Receivables
Hybrid
Low risk
DD review completed
Target net yield
10.9%
Expected net investor return under current structure.
Allocation volume
$4.1M
Total allocation need required to complete marketplace matching.
Tenor
128 days
Expected cycle from allocation close to settlement release.
Minimum ticket
$40,000
Minimum admissible allocation for participation.
Opportunity overview
- Exporter
- NovaLife API (India)
- Buyer
- Germany pharma distributor
- Commodity
- Machinery & equipment
- Corridor
- LATAM — Asia
- Model
- Insured Receivables
- Settlement rail
- Hybrid
- Investor access
- Institutional only
- Documents available
- Data room by request
Risk and protections
- Insurance coverage (Required) applied per corridor policy.
- Escrow mechanism (Mandatory) enforced for settlement protection.
- Counterparty and jurisdiction checks completed before opening allocation.
- Document registry enforces versioning and due diligence disclosure rules.
- Insurance, escrow, and settlement logic disclosed at term-sheet level.
DD review completed
Economics and protections
Return contourIndicative
Target 10.9% across 128 days with settlement through Hybrid.Protection stackMandatory
Insurance: Required · Escrow: Mandatory.Allocation perimeterRestricted
Minimum ticket $40,000 · investor access Institutional only · stage DD review.Underwriting dependenciesMonitoring
Advance rate, reserve logic, and final package remain tied to Data room by request disclosed and Under review readiness.Due diligence readiness
01Commercial packCore contract, buyer summary, and requested funding memo available.
02Legal packInsured Receivables memo and primary legal structure disclosed.
03ProtectionsInsurance (Required), escrow (Mandatory), and monitoring contours specified.
Route and corridor map
LATAM — Asia
Mode: Route validated in due diligence packETA: Transit plan under reviewStatus: Corridor feed active
OriginIndia
Exporter-side dispatch and first-mile preparation.
Planned corridorExport customs
Origin-side export and compliance checkpoint documented for the route.
DestinationGermany
Buyer-side delivery and settlement trigger location.
OriginIndiaExporter-side dispatch and first-mile preparation.
RouteLATAM — AsiaCore corridor, customs, or bonded transit checkpoint.
DestinationGermanyBuyer-side delivery and settlement trigger location.
Open deals show the planned export corridor before final logistics operators and milestone events are locked in.
Participants
01ExporterNovaLife API (India)
02BuyerGermany pharma distributor
03Settlement railHybrid
Telemetry and operator feed
01RouteOperational route available once execution begins.
02CarrierAssigned at execution activation.
03TelemetryIoT / milestone events appear in active mode.
Timeline and events
01Pre-checkCounterparties, country corridor, and product flow are screened.
02ReadinessDocument set validated and remediation notes attached.
03StructuringInsured Receivables structure, rail contour, and settlement waterfall are fixed.
04AllocationDocument set under review; remediation notes may be attached.
Execution and settlement
01Active
Protection continuityInsurance-backed exposure remains active until the next approved settlement trigger.02Controlled
Capital stateCapital deployment and settlement state change only on approved events.03Controlled
Reserve disciplineReserves and holdbacks remain controlled before release conditions are fully satisfied.04Controlled
Waterfall orderingFees, investor principal, and exporter residual follow approved waterfall sequencing.05Controlled
Rail and exception stateSettlement rail is active; no routing or drawdown exception currently open.06Pending
Next settlement triggerNext approved event needed before the settlement state can transition.07Controlled
Fallback settlementFallback settlement control describing how capital and release sequencing behave.Due diligence documents
| Document | Room | Status | Version | Action |
|---|---|---|---|---|
| Term sheet | Due diligence | Draft | Draft | |
| Commercial pack | Commercial | Pending | Draft | |
| Additional evidence | Disclosure | Pending | Draft |
Exceptions
01Monitoring
Control postureDD review in progress; counterparty checks pending.02Monitoring
Operational exceptionDocument SLA tracking active.Audit trail
01Recorded
Audit eventDeal record created and versioned in DFTP event registry.02Pending
Latest approvalPending final approval after document review completion.Need to Publish a New Export Deal?
Submit your structuring request and DFTP maps legal model, docs, readiness path, and allocation route.